日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Effect of treatment periods on efficacy of glecaprevir and pibrentasvir in chronic hepatitis C: A nationwide, prospective, multicenter study

治疗周期对格卡瑞韦和哌仑他韦治疗慢性丙型肝炎疗效的影响:一项全国性、前瞻性、多中心研究

Morita, Atsuhiro; Tamaki, Nobuharu; Kobashi, Haruhiko; Mori, Nami; Tsuji, Keiji; Takaki, Shintaro; Hasebe, Chitomi; Akahane, Takehiro; Ochi, Hironori; Mashiba, Toshie; Urawa, Naohito; Fujii, Hideki; Mitsuda, Akeri; Kondo, Masahiko; Ogawa, Chikara; Uchida, Yasushi; Narita, Ryoichi; Marusawa, Hiroyuki; Kubotsu, Yoshihito; Matsushita, Tomomichi; Shigeno, Masaya; Yoshida, Hideo; Tanaka, Katsuaki; Okamoto, Eisuke; Kasai, Toyotaka; Ishii, Toru; Okada, Kazuhiko; Kurosaki, Masayuki; Izumi, Namiki

Real-world long-term analysis of daclatasvir plus asunaprevir in patients with hepatitis C virus infection

达克拉他韦联合阿舒那韦治疗丙型肝炎病毒感染患者的真实世界长期分析

Fujii, Hideki; Kimura, Hiroyuki; Hasebe, Chitomi; Akahane, Takehiro; Satou, Takashi; Kusakabe, Atsunori; Kojima, Yuji; Kondo, Masahiko; Marusawa, Hiroyuki; Kobashi, Haruhiko; Tsuji, Keiji; Ogawa, Chikara; Uchida, Yasushi; Joko, Kouji; Mitsuda, Akeri; Kurosaki, Masayuki; Izumi, Namiki

The Real-World Data in Japanese Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib from a Nationwide Multicenter Study

来自一项全国多中心研究的日本不可切除肝细胞癌患者接受乐伐替尼治疗的真实世界数据

Tsuchiya, Kaoru; Kurosaki, Masayuki; Sakamoto, Azusa; Marusawa, Hiroyuki; Kojima, Yuji; Hasebe, Chitomi; Arai, Hirotaka; Joko, Kouji; Kondo, Masahiko; Tsuji, Keiji; Sohda, Tetsuro; Kimura, Hiroyuki; Ogawa, Chikara; Uchida, Yasushi; Wada, Shuichi; Kobashi, Haruhiko; Furuta, Koichiro; Shigeno, Masaya; Kusakabe, Atsunori; Akahane, Takehiro; Narita, Ryoichi; Yoshida, Hideo; Mitsuda, Akeri; Ide, Yasushi; Matsushita, Tomomichi; Izumi, Namiki; On Behalf Of Japanese Red Cross Liver Study Group

Complications after Radiofrequency Ablation for Hepatocellular Carcinoma: A Multicenter Study Involving 9,411 Japanese Patients

射频消融治疗肝细胞癌后的并发症:一项涉及9411名日本患者的多中心研究

Maeda, Masaki; Saeki, Issei; Sakaida, Isao; Aikata, Hiroshi; Araki, Yasuyuki; Ogawa, Chikara; Kariyama, Kazuya; Nouso, Kazuhiro; Kitamoto, Mikiya; Kobashi, Haruhiko; Sato, Shuichi; Shibata, Hiroshi; Joko, Kouji; Takaki, Shintaro; Takabatake, Hiroyuki; Tsutsui, Akemi; Takaguchi, Koichi; Tomonari, Tetsu; Nakamura, Shinichiro; Nagahara, Takakazu; Hiraoka, Atsushi; Matono, Tomomitsu; Koda, Masahiko; Mandai, Mari; Mannami, Tomohiko; Mitsuda, Akeri; Moriya, Takashi; Yabushita, Kazuhisa; Tani, Joji; Yagi, Takahito; Yamasaki, Takahiro

Real-world efficacy of elbasvir and grazoprevir for hepatitis C virus (genotype 1): A nationwide, multicenter study by the Japanese Red Cross Hospital Liver Study Group

艾尔巴韦和格拉佐普韦治疗丙型肝炎病毒(基因1型)的真实世界疗效:日本红十字会医院肝病研究组开展的一项全国多中心研究

Mashiba, Toshie; Joko, Kouji; Kurosaki, Masayuki; Ochi, Hironori; Hasebe, Chitomi; Akahane, Takehiro; Sohda, Tetsuro; Tsuji, Keiji; Mitsuda, Akeri; Kimura, Hiroyuki; Narita, Ryoichi; Ogawa, Chikara; Furuta, Koichiro; Shigeno, Masaya; Okushin, Hiroaki; Ito, Hiroshi; Kusakabe, Atsunori; Satou, Takashi; Kawanami, Chiharu; Nakata, Ryo; Kobashi, Haruhiko; Tamada, Takashi; Ide, Yasushi; Yagisawa, Hitoshi; Morita, Atsuhiro; Matsushita, Tomomichi; Okada, Kazuhiko; Izumi, Namiki

Does interferon-free direct-acting antiviral therapy for hepatitis C after curative treatment for hepatocellular carcinoma lead to unexpected recurrences of HCC? A multicenter study by the Japanese Red Cross Hospital Liver Study Group

肝细胞癌根治性治疗后,采用不含干扰素的直接抗病毒疗法治疗丙型肝炎是否会导致肝细胞癌意外复发?日本红十字医院肝病研究组的一项多中心研究

Mashiba, Toshie; Joko, Kouji; Kurosaki, Masayuki; Ochi, Hironori; Osaki, Yukio; Kojima, Yuji; Nakata, Ryo; Goto, Tohru; Takehiro, Akahane; Kimura, Hiroyuki; Mitsuda, Akeri; Kawanami, Chiharu; Uchida, Yasushi; Ogawa, Chikara; Kusakabe, Atsunori; Narita, Ryuichi; Ide, Yasushi; Abe, Takehiko; Tsuji, Keiji; Kitamura, Tadashi; Okada, Kazuhiko; Sohda, Tetsuro; Shigeno, Masaya; Satou, Takashi; Izumi, Namiki